Daaweynta Kansarka Caloosha
1 / 3

Daaweynta Kansarka Caloosha Qiimaha Hindiya

3,000 USD to 12,000 USD
Maalmaha cisbitaalka7
Maalmo ka baxsan isbitaalka21
Nidaamka nidaamka 240 daqiiqado
Heerka guusha70%-90%
Na soo celi
Na soo celi

Ku saabsan Daaweynta Kansarka Caloosha

Kansarka caloosha, oo sidoo kale loo yaqaan kansarka caloosha, wuxuu soo baxaa marka unugyo aan caadi ahayn ay si aan la xakameyn karin ugu koraan xuubka caloosha. Badanaa waxay ku bilaabataa aamusnaan, iyadoo calaamadaha hore ay yihiin kuwo khafiif ah ama si fudud loogu qalday arrimaha dheefshiidka caadiga ah. Sababtoo ah dad badan ma garanayaan calaamadaha digniinta, kansarka caloosha ayaa si joogta ah loo ogaadaa marxalad dambe, taasoo ka dhigaysa qiimeynta waqtiga iyo daaweynta mid aad muhiim u ah.

 

Caalamka, kansarka caloosha ayaa weli ah mid ka mid ah sababaha ugu waaweyn ee dhimashada kansarka la xiriira. In ka badanhal milyan oo kiis oo cusubsanad walba waa la ogaadaa, waxayna ka mid tahayshanta kansar ee ugu caansan aduunka. In kasta oo ay xaaladdu hoos u dhacday gobollada qaar iyadoo ay ugu wacan tahay ilaalinta cuntada oo wanaagsan iyo cuntada oo la roonaaday, haddana waxay sii waddaa inay saamayso dadka da' kasta ah, gaar ahaan kuwa da'doodu tahay 50 iyo wixii ka weyn. Horumarka tignoolajiyada ogaanshaha, daawaynta la beegsaday, iyo qalliinka ugu yar ee qalliinka ayaa si weyn u hagaajiyay natiijooyinka bukaanno badan.

 

Waa maxay Kansarka Caloosha?

Kansarka caloosha waa cudur ay unugyo aan caadi ahayn ay ku koraan xuubka caloosha oo ay sameeyaan buro. Waxay caadi ahaan ka bilaabataa lakabka ugu hooseeya ee gidaarka caloosha waxayna sii faafi kartaa qoto dheer waqti ka dib haddii aan la daweyn.

 

Nooca ugu caansan waaadenocarcinoma, kaas oo ka soo baxa unugyada qanjidhada ee soo saara xabka iyo dareeraha dheefshiidka. Iyadoo adenocarcinoma ay xisaabiso inta badan kiisaska, noocyada kale ee kansarka caloosha ayaa sidoo kale dhaca:

 

  • Burooyinka Stromal ee mindhicirku (GISTs):Burooyinkan waxay ka soo baxaan unugyada isku xidha ee caloosha waxayna badanaa u dhaqmaan si ka duwan kansarka caloosha ee caadiga ah.
  • Lymphoma:Noocani wuxuu ka bilaabmaa unugyada difaaca ee gudaha xuubka caloosha.
  • Burooyinka Neuroendocrine:Kansarradani waxay ka bilaabmaan unugyada hormoonnada soo saara ee caloosha.

Kansarka caloosha si tartiib ah ayuu u korayaa waxaana laga yaabaa in aan la dareemin marxaladaha hore. Marka kansarka caloosha uu sii socdo, wuxuu ku fidi karaa qanjidhada qanjidhada u dhow, hunguriga, xiidmaha yar, ama xubnaha fog.

 

Waa maxay Calaamadaha Kansarka Caloosha?

Kansarka caloosha wuxuu inta badan ku bilaabmaa calaamado fudud ama aan caddayn, taas oo ka dhigaysa in goor hore la ogaado mid adag. Calaamado badan oo hore waxay u egyihiin dhibaatooyinka dheefshiidka caadiga ah, markaa, bukaanku way iska indhatiraan iyaga. Aqoonsiga calaamadaha goor hore waxay gacan ka geysataa hubinta qiimeynta waqtiga iyo natiijooyinka daaweynta ee wanaagsan.

 

Calaamadaha hore

Calaamadahani waa kuwo aan fiicneyn waxaana laga yaabaa inay yimaadaan oo tagaan:

 

  • Calool-xumo joogto ah ama laab-jeex
  • Dareen dheregsan ka dib markaad wax yar cunto
  • Xanuunka caloosha sare ee fudud
  • Daal aan la garanayn
  • Cunto beelid

Calaamadaha Horukacsan

Marka kansarku sii kordho, astaamuhu waxay noqonayaan kuwo la dareemo oo joogto ah:

 

  • Miisaan culus oo luma
  • Liqitaanka oo ku adag
  • Lalabbo ama matag joogto ah
  • Calool xanuun oo ka sii dara muddo ka dib
  • Dhiig ku jira matag ama saxaro
  • Dareemidda daciifnimo ama dawakhsanaan la'aan awgeed
  • Dhiigbaxa cuntada ka dib

Sidee Lagu Ogaaday Kansarka Caloosha?

Dhakhaatiirtu waxay isticmaalaan isku darka baarista endoscopic, sawir-qaadista, iyo qiimaynta shaybaadhka si ay si sax ah u ogaadaan kansarka caloosha. Baadhitaanadani waxay caawiyaan in la aqoonsado burada, go'aaminta heerkeeda, iyo abuurista qorshe daaweyn ku haboon.

 

  • GI sare ee endoscopy:Tani waa baaritaanka ogaanshaha ugu muhiimsan. Dhakhtarku waxa uu caloosha geliyey tuubo dhuuban, dabacsan oo kamarad wadata si uu u eego xuubka xuubka oo uu u ogaado koritaan aan caadi ahayn.
  • Biopsy:Inta lagu jiro endoscopic, dhakhtarku wuxuu ka soo ururiyaa shaybaarka unugyada yaryar meelaha laga shakiyo. Biopsi ayaa xaqiijisa in unugyadu yihiin kansar iyo in kale.
  • CT Scan ama MRI:Tijaabooyinka sawir-qaadista waxay muujinayaan cabbirka burada waxayna caawiyaan in la ogaado inuu kansarku ku faafay xubnaha kale ama qanjidhada qanjidhada.
  • Baaritaanka PET-CT:PET-CT waxay daaha ka qaadaysaa unugyada kansarka firfircoon ee jidhka waxayna ka caawisaa dhakhaatiirta inay ogaadaan metastases fog iyo nabarada qarsoon.
  • Ultrasound Endoscopic (EUS):EUS waxay si faahfaahsan u eegaysaa sida qoto dheer ee buradu u soo gashay gidaarka caloosha iyo haddii qanjidhada u dhow ay saamaysay.
  • Tijaabada Dhiiga:Dhakhaatiirtu waxay isticmaalaan baaritaannada dhiigga si ay u eegaan dhiig-yarida, caabuqa, shaqada beerka, iyo heerka nafaqada. Calaamadaha burooyinka ayaa sidoo kale laga yaabaa in la qiimeeyo xaaladaha qaarkood.
  • Habaynta Shaqada:Ka dib marka ay dhammeeyaan dhammaan tijaabooyinka, kooxda caafimaadku waxay soo saaraan kansarka, kaas oo haga qalliinka, daaweynta kiimoterabiga, iyo go'aamada daawaynta ee la beegsaday.

Waa maxay Ikhtiyaarada Daawaynta Ugu Danbeeyay ee Kansarka Caloosha?

Dhakhaatiirtu waxay adeegsadaan qalliin isugu jira, daawayn ku salaysan dawooyin, iyo daryeel taageero si loo daweeyo kansarka caloosha. Qorshaha daaweyntu wuxuu ku xiran yahay heerka cudurka, caafimaadka guud ee bukaanka, iyo meesha ay burotu ku taal iyo xajmiga.

 

  • Qalliin:Ka saarista qaliinka ayaa ah daawaynta ugu waxtarka badan ee kansarka caloosha ee hore iyo gudaha. Dhakhtarka qaliinka ayaa laga yaabaa inuu ka saaro qayb ka mid ah caloosha (wadarta guud ee gastrectomy) ama caloosha oo dhan (guud ahaan gastrectomy) ku salaysan fiditaanka burada. Sidoo kale waxaa la saaraa qanjidhada ku wareegsan si looga hortago faafitaan kale.
  • Chemotherapy:Chemo waxay isticmaashaa dawooyin xooggan si ay u disho unugyada kansarka. Dhakhaatiirtu waxay ku siin karaan daawaynta kiimiko ka hor qalliinka si ay u yareeyaan burada ama qalliinka ka dib si loo baabi'iyo unugyada kansarka ee soo hadhay. Chemotherapy sidoo kale waxaa lagu siin karaa kiisaska horumarsan si loo yareeyo horumarka loona hagaajiyo calaamadaha.
  • Daaweynta Shucaaca:Daaweynta shucaaca waxay isticmaashaa alwaaxyo la beegsaday si loo burburiyo unugyada kansarka. Waxaa laga yaabaa in lagu daro kiimoterabi si kor loogu qaado waxtarka, gaar ahaan xaaladaha meesha aan burada gebi ahaanba laga saari karin.
  • Daaweynta La Beegsado:Daawooyinkani waxay ku shaqeeyaan borotiinno gaar ah ama waddooyinka unugyada kansarka. Waxay faa'iido u leeyihiin bukaanada qaba kansarka caloosha ee HER2 ama burooyinka leh isbeddello gaar ah oo hidde ah.
  • Immunotherapy:Immunotherapy waxay kicisaa habka difaaca bukaanka si loo aqoonsado oo u weeraro unugyada kansarka. Waxaa badanaa loo isticmaalaa kansarka caloosha ee sareeyo ama marka daawaynta caadiga ahi shaqayn waayaan.
  • Daawaynta Endoscopic (Cudurka Marxaladda Hore):Burooyinka aadka u horreeya, dib-u-soo-celinta xuubka xuubka endoscopic (EMR) ama xuubka xuubka xuubka hoose (ESD) ayaa u oggolaanaya dhakhaatiirta inay ka saaraan kansarka iyada oo aan qaliin furan.
  • Daryeelka Palliative:Marka kansarku horumaro, daryeelka palliative wuxuu caawiyaa maareynta calaamadaha, hagaajinta raaxada, iyo ilaalinta tayada nolosha.
  • Daaweynta kansarka caloosha inta badan waxay ku lug leedahay habab badan si loo gaaro natiijada ugu wanaagsan ee suurtogalka ah.

Hel qorshe daaweyn oo bilaash ah

Dooro Dalka
  • INIndia (भारत)+91
  • USUnited States of America+1
  • AFAfghanistan (‫افغانستان‬‎)+93
  • ALAlbania (Shqipëri)+355
  • DZAlgeria (‫الجزائر‬‎)+213
  • ASAmerican Samoa+1
  • ADAndorra+376
  • AOAngola+244
  • AIAnguilla+43
  • AGAntigua and Barbuda+1
  • ARArgentina+54
  • AMArmenia (Հայաստան)+374
  • AWAruba+297
  • AUAustralia+61
  • ATAustria (Österreich)+43
  • AZAzerbaijan (Azərbaycan)+994
  • BSBahamas+1
  • BHBahrain (‫البحرين‬‎)+973
  • BDBangladesh (বাংলাদেশ)+880
  • BBBarbados+1
  • BYBelarus (Беларусь)+375
  • BEBelgium (België)+32
  • BZBelize+501
  • BJBenin (Bénin)+229
  • BMBermuda+1
  • BTBhutan (འབྲུག)+975
  • BOBolivia (Plurinational State of)+591
  • BABosnia and Herzegovina (Босна и Херцеговина)+387
  • BWBotswana+267
  • BRBrazil (Brasil)+55
  • IOBritish Indian Ocean Territory+246
  • VGVirgin Islands (British)+1
  • VIVirgin Islands (U.S.)+1
  • BNBrunei Darussalam+673
  • BGBulgaria (България)+359
  • BFBurkina Faso+226
  • BIBurundi (Uburundi)+257
  • KHCambodia (កម្ពុជា)+855
  • CMCameroon (Cameroun)+237
  • CACanada+1
  • CVCape Verde (Kabu Verdi)+238
  • KYCayman Islands+1
  • CFCentral African Republic (République centrafricaine)+236
  • CLChile+56
  • CNChina (中国)+86
  • COColombia+57
  • KMComoros (‫جزر القمر‬‎)+269
  • CGCongo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+242
  • CDCongo (Republic) (Congo-Brazzaville)+243
  • CKCook Islands+682
  • CRCosta Rica+506
  • HRCroatia (Hrvatska)+385
  • CUCuba+53
  • CYCyprus (Κύπρος)+357
  • CZCzech Republic (Česká republika)+420
  • DKDenmark (Danmark)+45
  • DJDjibouti+253
  • DMDominica+1
  • DODominican Republic (República Dominicana)+1
  • ECEcuador+593
  • EGEgypt (‫مصر‬‎)+20
  • SVEl Salvador+503
  • GQEquatorial Guinea (Guinea Ecuatorial)+240
  • EREritrea+291
  • EEEstonia (Eesti)+372
  • ETEthiopia+251
  • FKFalkland Islands (Islas Malvinas)+500
  • FOFaroe Islands (Føroyar)+298
  • FJFiji+679
  • FIFinland (Suomi)+358
  • FRFrance+33
  • GFFrench Guiana (Guyane française)+594
  • PFFrench Polynesia (Polynésie française)+689
  • GAGabon+241
  • GMGambia+220
  • GEGeorgia (საქართველო)+995
  • DEGermany (Deutschland)+49
  • GHGhana (Gaana)+233
  • GIGibraltar+350
  • GRGreece (Ελλάδα)+30
  • GLGreenland (Kalaallit Nunaat)+299
  • GDGrenada+1
  • GPGuadeloupe+590
  • GUGuam+1
  • GTGuatemala+502
  • GNGuinea (Guinée)+224
  • GWGuinea-Bissau (Guiné Bissau)+245
  • GYGuyana+592
  • HTHaiti+509
  • VAHoly See+39
  • HNHonduras+504
  • HKHong Kong (香港)+852
  • HUHungary (Magyarország)+36
  • ISIceland (Ísland)+354
  • IDIndonesia+62
  • CICôte d'Ivoire+225
  • IRIran (‫ایران‬‎)+98
  • IQIraq (‫العراق‬‎)+964
  • IEIreland+353
  • ILIsrael (‫ישראל‬‎)+972
  • ITItaly (Italia)+39
  • JMJamaica+1
  • JPJapan (日本)+81
  • JOJordan (‫الأردن‬‎)+962
  • KZKazakhstan (Казахстан)+7
  • KEKenya+254
  • KIKiribati+686
  • KWKuwait (‫الكويت‬‎)+965
  • KGKyrgyzstan (Кыргызстан)+996
  • LALaos (ລາວ)+856
  • LVLatvia (Latvija)+371
  • LBLebanon (‫لبنان‬‎)+961
  • LSLesotho+266
  • LRLiberia+231
  • LYLibya (‫ليبيا‬‎)+218
  • LILiechtenstein+423
  • LTLithuania (Lietuva)+370
  • LULuxembourg+352
  • MOMacau (澳門)+853
  • MKMacedonia (the former Yugoslav Republic of)+389
  • MGMadagascar (Madagasikara)+261
  • MWMalawi+265
  • MYMalaysia+60
  • MVMaldives+960
  • MLMali+223
  • MTMalta+356
  • MHMarshall Islands+692
  • MQMartinique+596
  • MRMauritania (‫موريتانيا‬‎)+222
  • MUMauritius (Moris)+230
  • YTMayotte+262
  • MXMexico (México)+52
  • FMMicronesia (Federated States of)+691
  • MDMoldova (Republica Moldova)+373
  • MCMonaco+377
  • MNMongolia (Монгол)+976
  • MEMontenegro (Crna Gora)+382
  • MSMontserrat+1
  • MAMorocco (‫المغرب‬‎)+212
  • MZMozambique (Moçambique)+258
  • MMMyanmar (Burma) (မြန်မာ)+95
  • NANamibia (Namibië)+264
  • NRNauru+674
  • NPNepal (नेपाल)+977
  • NLNetherlands (Nederland)+31
  • NCNew Caledonia (Nouvelle-Calédonie)+687
  • NZNew Zealand+64
  • NINicaragua+505
  • NENiger (Nijar)+227
  • NGNigeria+234
  • NUNiue+683
  • NFNorfolk Island+672
  • KPNorth Korea (조선 민주주의 인민 공화국)+850
  • MPNorthern Mariana Islands+1
  • NONorway (Norge)+47
  • OMOman (‫عُمان‬‎)+968
  • PKPakistan (‫پاکستان‬‎)+92
  • PWPalau+680
  • PSPalestine (‫فلسطين‬‎)+970
  • PAPanama (Panamá)+507
  • PGPapua New Guinea+675
  • PYParaguay+595
  • PEPeru (Perú)+51
  • PHPhilippines+63
  • PLPoland (Polska)+48
  • PTPortugal+351
  • PRPuerto Rico+1
  • QAQatar (‫قطر‬‎)+974
  • XKRepublic of Kosovo+381
  • RERéunion (La Réunion)+262
  • RORomania (România)+40
  • RURussia (Россия)+7
  • RWRwanda+250
  • BLSaint Martin (Saint-Martin (partie française))+590
  • SHSaint Helena, Ascension and Tristan da Cunha+290
  • KNSaint Kitts and Nevis+1
  • LCSaint Lucia+1
  • MFSaint Martin (French part)+590
  • PMSaint Pierre and Miquelon+508
  • VCSaint Vincent and the Grenadines+1
  • WSSamoa+685
  • SMSan Marino+378
  • STSão Tomé and Príncipe (São Tomé e Príncipe)+239
  • SASaudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • SNSenegal (Sénégal)+221
  • RSSerbia (Србија)+381
  • SCSeychelles+248
  • SLSierra Leone+232
  • SGSingapore+65
  • SKSlovakia (Slovensko)+421
  • SISlovenia (Slovenija)+386
  • SBSolomon Islands+677
  • SOSomalia (Soomaaliya)+252
  • ZASouth Africa+27
  • KRSouth Korea (대한민국)+82
  • ESSpain+34
  • LKSri Lanka (ශ්‍රී ලංකාව)+94
  • SDSudan (‫السودان‬‎)+249
  • SRSuriname+597
  • SZSwaziland+268
  • SESweden (Sverige)+46
  • CHSwitzerland (Schweiz)+41
  • SYSyria (‫سوريا‬‎)+963
  • TWTaiwan (台灣)+886
  • TJTajikistan+992
  • TZTanzania, United Republic of+255
  • THThailand+66
  • TLTimor-Leste+670
  • TGTogo+228
  • TKTokelau+690
  • TOTonga+676
  • TTTrinidad and Tobago+1
  • TNTunisia (‫تونس‬‎)+216
  • TRTurkey (Türkiye)+90
  • TMTurkmenistan+993
  • TCTurks and Caicos Islands+1
  • TVTuvalu+688
  • UGUganda+256
  • UAUkraine (Україна)+380
  • AEUnited Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • GBUnited Kingdom of Great Britain and Northern Ireland+44
  • UYUruguay+598
  • UZUzbekistan (Oʻzbekiston)+998
  • VUVanuatu+678
  • VEVenezuela (Bolivarian Republic of)+58
  • VNVietnam (Việt Nam)+84
  • WFWallis and Futuna (Wallis-et-Futuna)+681
  • YEYemen (‫اليمن‬‎)+967
  • ZMZambia+260
  • ZWZimbabwe+263

Qiyaastii Daaweynta Kansarka Caloosha gudaha Hindiya

Immisa ayuu ku kacayaa daawaynta kansarka caloosha ee Hindiya?

Celceliska qiimaha daawaynta kansarka caloosha ee Hindiya waxay caadi ahaan u dhaxaysaa$3,000 ilaa $12,000(qiyaastii2.5 lakh ilaa 10 lakh). Qiimaha ugu dambeeya wuxuu ku xiran yahay heerka kansarka, nooca daawaynta, tirada wareegyada kemotherabi, baahiyaha isbitaal dhigista, iyo isticmaalka la beegsaday ama daawooyinka difaaca jirka.

 

Hoos waxaa ku qoran faahfaahin faahfaahsan oo ku saabsan kharashyada daawaynta.

Nooca Daawaynta

Celceliska Qiimaha (USD)

Qiyaastii Qiimaha (INR)

Qalliinka Gastrectomy Qayb ah$3,000 – $6,0002.5 - 5 lakh
Wadarta Qalliinka Gastrectomy$4,000 – $7,0003.3 - 5.8 lakh
Chemotherapy (wareeg kasta)$200 – $400₹16,000 - 32,000
6–8 Wareegyada Daaweynta Kiimikada (Wadarta)$1,200 – $3,2001 - 2.6 lakh
Daaweynta Shucaaca$1,500 – $3,0001.2 - 2.5 lakh
Daawaynta la beegsaday (bishii)$800 – $2,50065,000 - 2 lakh
Immunotherapy (halkiiba)$1,500 – $4,0001.2 - 3.3 lakh
Dib u soo celinta Endoscopic (EMR/ESD)$2,000 – $4,0001.6 - 3.3 lakh
  • Marxaladaha horumarsan waxay caadi ahaan u baahan yihiin qalliin, kiimoterabi, iyo daawaynta la beegsaday.
  • Daawooyinka la bartilmaameedsado iyo kuwa difaaca jirka ayaa si weyn u kordhiya wadarta qiimaha.
  • Qaybta isbitaalka (standard vs. premium) sidoo kale waxay saamaysaa qiimaha.

Waxa Qiimaha Ku Jira

  • Kharashka dhakhtarka qalliinka ee gastrectomy ama hababka endoscopic
  • Lacagta suuxinta
  • Tiyaatarka hawlgalka iyo isticmaalka qalabka
  • Joogitaanka isbitaalka (qol, daryeelka kalkaalinta, la socodka)
  • Daawooyinka caadiga ah inta lagu jiro qaadashada
  • Tijaabooyin dhiig oo joogto ah ka hor qalliinka
  • Daryeelka qaliinka kadib inta lagu jiro isbitaalka
  • Hal booqasho dabagal ah ka dib bixitaan
  • Kharashaadka faleebada kiimoterabiga (haddii qayb ka mid ah xirmo)

Cutubyadani waxay daboolayaan shuruudaha caafimaad ee aasaasiga ah ee qalliinka ama fadhiyada daawaynta ku salaysan cusbitaalka.

 

Maxaa Kharashka Ka Reeban

  • Baaritaannada PET-CT iyo sawir-qaadista horumarsan
  • Tijaabooyinka hidda-socodka ama biomarker (HER2, MSI, PD-L1, iwm.)
  • Daawooyinka daawaynta la beegsaday (Qaybta qaaliga ah)
  • Irbadaha Immunotherapy
  • Daawooyinka kiimoterabiga (waxaa lagu dallacaa si gooni gooni ah isbitaallada intooda badan)
  • Joogitaanka cusbitaalka oo la dheereeyey sababo la xiriira dhibaatooyin ama soo kabasho gaabis ah
  • Tijaabooyinka daba-galka muddada-dheer
  • Maareynta arrimaha caafimaadka ee hore u jiray
  • Socdaalka, cunnada, fiisaha, iyo hoyga bukaannada caalamiga ah

Ka-reebitaankani way ku kala duwan yihiin isbitaallada, sidaa darteed bukaannadu waxay inta badan codsadaan qiyaas faahfaahsan ka hor intaysan bilaabin daaweynta.

 

Waa maxay Kharashka Daaweynta Kansarka Caloosha ee Magaalooyinka kala duwan ee Hindiya?

Qiimaha daaweynta kansarka caloosha ayaa ku kala duwan hal magaalo oo Hindi ah ilaa magaalo kale, iyadoo ku xiran heerarka isbitaallada, khibradda dhakhtarka qalliinka, tignoolajiyada la isticmaalo, iyo kakanaanta daaweynta. Magaalooyinka metro waxay inta badan bixiyaan lacag ka badan sababtoo ah waxay bixiyaan unugyo kansar oo horumarsan iyo dhakhaatiirta ku takhasusay kansarka, halka magaalooyinka heerka 2 ay bixiyaan doorashooyin dhaqaale oo badan oo leh daryeel la isku halayn karo.

 

Hoos waxaa ku yaal isbarbardhigga caqli-magaaleed si looga caawiyo bukaannada qorsheynta daaweyntooda iyo miisaaniyaddooda.

Magaalada

Celceliska Qiimaha Daaweynta (USD)

Qiyaastii Qiimaha (INR)

New Delhi$4,000 – $10,0003.3 - 8.3 lakh
Mumbai$4,200 – $12,0003.5 - 10 lakh
Bangalore$3,500 – $9,5002.9 - 7.8 lakh
Chennai$3,200 – $9,0002.6 - ₹ 7.4 lakh
Hyderabad$3,500 – $9,5002.9 - 7.8 lakh
  • Delhi iyo Mumbaibixiyaan qaar ka mid ah xarumaha kansarka ee aadka u horumaray ee heli kara qalliinka robotka, sawirka PET-CT, iyo kooxo khaas ah oo kansarka caloosha ku jira.
  • Bangalore iyo Hyderabadku bixi daryeel tayo sare leh oo qiimo tartan leh iyo waaxyo oncology xoog leh.
  • Chennaiwaxaa lagu yaqaanaa dhakhaatiirta qaliinka caloosha iyo mindhicirka ee khibrada leh iyo dariiqooyinka daryeelka kansarka habaysan ee heerar la awoodi karo.

Maxay yihiin Qodobbada Saameynaya Qiimaha Daaweynta Kansarka Caloosha ee Hindiya?

Qiimaha daaweynta kansarka caloosha aad ayuu u kala duwan yahay sababtoo ah bukaan kastaa wuxuu u baahan yahay hab shakhsi ahaaneed oo ku salaysan marxaladda cudurka iyo qorshaha daaweynta. Dhowr arrimood oo caafimaad iyo saadka ayaa saameeya wadarta kharashka.

 

  • Heerka Kansarka ee ogaanshaha:Kansarrada marxaladda hore inta badan waxay u baahan yihiin qalliin oo keliya, halka heerarka horumarsan laga yaabo inay u baahdaan daawayn badan sida kiimoterabiga, shucaaca, daawaynta la beegsanayo, iyo daaweynta difaaca jirka.
  • Nooca daawaynta loo baahan yahay:Qalliinka, kiimoterabiga, daaweynta shucaaca, iyo daawooyinka la beegsaday mid kastaa wuxuu leeyahay qiime kala duwan. Daaweynta isku dhafan waxay kordhisaa kharashka guud.
  • Tirada wareegyada kiimoterabiga:Dhakhaatiirtu waxay ku talinayaan 6-8 wareegyo bukaanno badan. Wareegyo badan iyo dawooyinka xoogga badan ayaa kordhiya wadarta kharashka daaweynta.
  • Baahida Daawaynta Bartilmaameedsan ama Immunotherapy:Daawooyinka sida Trastuzumab iyo isbaarada xannibaadaha ayaa si weyn u kordhiya wadarta kharashka sababtoo ah qiimahooda sarreeya.
  • Qalliinka Kakanaanta:Gastrectomy qayb ah ayaa ka kharash yar wadarta guud ee caloosha. Qalliinada robotic-ku caawiyay waxa kale oo laga yaabaa inay leeyihiin kharashyo badan.
  • Qeybta Isbitaalka iyo Xarumaha:Isbitaalada qiimaha leh ee leh ICU-yo horumarsan, unugyo takhasus u leh kansarka, iyo aqoonsiga caalamiga ah ayaa lacag ka badan isbitaalada dhexe.
  • Khabiirka Kansarka iyo Dhakhaatiirta Qalliinka:Khabiirada kansarka leh ee khibrada u leh ayaa laga yaabaa inay leeyihiin la-talin sare iyo khidmadaha habraaca, laakiin khibraddooda ayaa hagaajinaysa badbaadada iyo natiijooyinka.
  • Muddada Joogitaanka Cisbitaalka:Joogitaanka dheeraadka ah ee ay sababto dhibaatooyinka, taageerada nafaqeynta, ama la socodka qalliinka kadib ayaa ku kordhinaysa wadarta biilka.
  • Baahiyaha Daryeelka Taageerada:Kaabista nafaqada, dhiig ku shubista, daryeelka palliative, iyo maaraynta caabuqa waxay kordhin kartaa kharashyada bukaanada qaarkood.

Sidee Qiimaha Hindiya U Barbar Dhigaa Wadamada Kale?

Daaweynta kansarka caloosha ayaa si aad ah uga jaban Hindiya marka loo eego waddamo badan oo reer galbeedka iyo Aasiya ah. Inkasta oo qiimaha hooseeya, bukaannada Hindiya waxay helayaan daryeel heer caalami ah oo ay ka helaan kooxo khibrad leh oo oncology ah oo ku qalabaysan qalab casri ah oo lagu ogaanayo iyo farsamooyinka daaweynta sare.

 

Hoos waxaa ku yaal isbarbardhigga celceliska kharashyada daawaynta ee dhammaan goobaha caanka ah ee caafimaadka:

Dalka

Celceliska Qiimaha (USD)

Maraykanka$20,000 – $60,000
Boqortooyada Ingiriiska$18,000 – $45,000
Singapore$15,000 – $35,000
UAE$12,000 – $30,000
Thailand$10,000 – $25,000
Hindiya$3,000 – $12,000

Bukaanka wax badbaadiya60% ilaa 80%marka ay Hindiya u doortaan daaweynta kansarka caloosha, iyada oo aan la dhimin khibradda caafimaad ama tignoolajiyada. Hindiya waxay bixisaa daryeel kansar heersare ah oo leh qorshooyin daawaynta shakhsi ahaaneed oo qayb yar ka ah qiimaha caalamiga ah.

 

Maxay tahay sababta aad India ugu doorato daawaynta kansarka caloosha?

Hindiya waxay noqotay meesha ugu horeysa ee daaweynta kansarka caloosha sababtoo ah tas-hiilaadkeeda horumarinta oncology, khabiiro khibrad leh, iyo daryeel aad u jaban. Bukaannada ka kala socda adduunka oo dhan waxay u safraan Hindiya sababtoo ah waxay helaan daaweyn dhamaystiran oo leh natiijooyin aad u fiican oo qiimo jaban ah oo caalami ah.

 

  • Dhakhaatiirta Kansarka ee Khibrada leh iyo Dhakhaatiirta GI:Hindiya waxay leedahay kooxo xirfad leh oo ah dhakhaatiirta qaliinka ee kansarka, dhakhaatiirta qaliinka caloosha, iyo dhakhaatiirta caafimaadka kansarka kuwaas oo si joogto ah u daaweeya xaaladaha adag ee kansarka caloosha.
  • Cisbitaalada Sare ee Kansarka iyo Tignoolajiyada:Xarumo badan oo kansar ah ayaa bixiya qalab casri ah oo lagu baaro, oo ay ku jiraan PET-CT, ultrasound endoscopic, qalliinka robotka, iyo sawir-qaadista sare, si ay u taageeraan diyaarinta saxda ah iyo qorsheynta daaweynta.
  • Daryeelka Dhameystiran ee Hal Saqafka Hoostiisa:Isbitaaladu waxay bixiyaan dariiqooyin daaweyn oo dhamaystiran, laga bilaabo ogaanshaha iyo qaliinka ilaa kiimoterabiga, taageerada nafaqeynta, iyo baxnaanintu, taasoo ka dhigaysa habka mid aan kala go 'lahayn.
  • Waqtiyo Sugitaan oo Gaaban:Bukaanku si dhakhso ah ayey u bilaabi karaan daawaynta, taas oo muhiim u ah kansarrada sida kansarka caloosha oo si degdeg ah u socda.
  • Taageerada Go'an ee Bukaan-socodka Caalamiga ah:Isbitaaladu waxay ka caawiyaan waraaqaha fiisaha caafimaadka, wareejinta garoonka diyaaradaha, adeegyada tarjumaada, hagida hoyga, iyo daryeelka dabagalka.
  • Habka Dhameystiran iyo Nidaamyada Kala Duwan:Khabiiro ka kala socda waaxyo kala duwan ayaa iska kaashada si ay u horumariyaan qorshooyinka daawaynta ee ku habboon heerka bukaanka, caafimaadka, iyo bayoolajiga burada.

Waa maxay Heerka Soo-kabashada iyo Guusha Ka dib Daaweynta Kansarka Caloosha?

Soo kabashada kansarka caloosha ka dib daaweynta waxay ku xiran tahay nooca daawaynta la helay, heerka cudurka, iyo guud ahaan caafimaadka bukaanka. Hababka daaweynta casriga ah iyo daryeelka taageerada ee la wanaajiyey, bukaanku waxay la kulmaan soo kabasho fudud iyo natiijooyin wanaagsan oo waqti dheer ah.

 

Soo kabashada Qalitaanka Kadib (Gastrectomy)

  • Todobaadka Koowaad:Bukaanku waxay joogaan cisbitaalka si ay ula socdaan, xakamaynta xanuunka, dareeraha IV, iyo taageerada nafaqeynta.
  • 2-4 toddobaad:Heerarka tamarta ayaa soo hagaagaya, bukaannadu waxay bilaabaan inay cunaan cuntooyinka jilicsan iyadoo la raacayo hagidda dhakhtarka cuntada.
  • 6-8 toddobaad:Bukaanjiifka badankoodu waxay ku soo noqdaan hawlihii caadiga ahaa waxayna dib u bilaabaan hawl-maalmeed caadi ah oo cuntooyin yar yar, soo noqnoqda.

Soo kabashada Inta lagu jiro daweynta Chemotherapy

Wareegyada kemotherabi waxay sababi karaan daal, cunto beddelasho, lallabbo, ama daciifnimo fudud. Dhakhaatiirtu waxay ku maareeyaan saameyntan daawooyinka taageerada ah, iyagoo u oggolaanaya bukaanada intooda badan inay sii wadaan waxqabadyada maalinlaha ah iyagoo hagaajinaya.

 

Soo kabashada ka dib daaweynta shucaaca

Shucaaca ayaa keeni kara daal ku meel gaar ah iyo raaxo la'aan dheefshiidka. Dhibaatooyinkan soo raaca waxay caadi ahaan soo roonaadaan dhowr toddobaad ka dib marka la dhammeeyo daaweynta.

 

Heerka Guusha ee Daaweynta Kansarka Caloosha

Heerarka guushu waxay inta badan ku xiran tahay ogaanshaha hore iyo nooca daaweynta:

 

  • Kansarka caloosha ee marxaladda hore:Heerarka badbaadada ayaa aad u sarreeya marka burada la ogaado ka hor intaysan faafin. Bukaanno badan ayaa ku guulaysta cafiska muddada dheer qaliinka ka dib.
  • Kansar maxalli ah oo horumaray:Daaweynta isku darka qalliinka kiimoterabiga ama shucaaca ayaa si weyn u wanaajinaya natiijooyinka.
  • Kansarka sare:Daawaynta casriga ah sida daawaynta la beegsaday iyo immunotherapy waxay gacan ka geystaan ​​xakamaynta cudurka, fududaynta calaamadaha, waxayna kordhiyaan badbaadada.

Daaweynta Kansarka Caloosha Isbarbardhigga Qiimaha Dal ahaan

Isbarbar dhig bogga

Baaddiye Kala duwanaanshaha qiimaha (USD) Kaydinta suurtagalka ah Waxqabad
HindiyaQul-qulQiimaha ugu fiican
$3,000 - $12,000 Soo xigasho

Xusuusin: Kharashaadka ayaa ku kala duwanaan kara iyadoo lagu saleynayo doorashada isbitaalka, nooca qolka, adeegyada dheeraadka ah, iyo baahiyaha caafimaad ee shaqsiyadeed.

Cisbitaalada hogaaminaya Daaweynta Kansarka Caloosha gudaha Hindiya

Park Medical Bahcelievler Hospital

Istanbul, Turkiga
Multi Specialty
Aasaasay 2007
242 Sariiraha

Medical Park Bahcelievler Hospital waa cisbitaal la aqoonsan yahay JCI oo leh 242 sariirood oo ku yaal Istanbul, oo la aasaasay 2007. Ku faafaya 33,00...

Aqoonsado
Joint Commission International (JCI)
Gadawiya xarumaha
+11

Hisar Intercontinental Hospital, Istanbul

Istanbul, Turkiga
Multi Specialty
Aasaasay 2005
212 Sariiraha

Cisbitaalka Hisar Intercontinental Hospital ee Istanbul waa JCI-ay aqoonsantahay, cusbitaal gaar ah oo leh 212 sariirood oo leh 35,000 mitir oo laba j...

Aqoonsado
Joint Commission International (JCI)
Gadawiya xarumaha
+11

Isbitaalka Medipol Bahçelievler

Istanbul, Turkiga
Multi Specialty
Aasaasay 2022
441 Sariiraha

Medipol Bahçelievler Hospital waa cisbitaal gaar loo leeyahay oo leh 441 sariirood oo ku yaala Istanbul oo bilaabay hawlgal bishii May 2022. Oo dabool...

Aqoonsado
Joint Commission International (JCI)
Gadawiya xarumaha
+11

Nidaamyada la midka ah

Chemotherapy gudaha Hindiya

1,200 USD to 6,000 USD

Immunotherapy gudaha Hindiya

1,800 USD to 4,500 USD

Shucaaca-Raaca La Habeeyay (IMRT) gudaha Hindiya

3,000 USD to 7,200 USD

Daawaynta La Beegsado gudaha Hindiya

1,800 USD to 4,800 USD

Daaweynta Kansarka Maskaxda gudaha Hindiya

6,500 USD to 15,000 USD

Daaweynta Kansarka Naasaha gudaha Hindiya

2,500 USD to 12,000 USD

Daaweynta Kansarka Afka gudaha Hindiya

3,500 USD to 8,000 USD

Daaweynta Kansarka Maqaarka gudaha Hindiya

1,500 USD to 6,000 USD

Warqad maqas

Caafimaad ahaan waxaa dib u eegayDr. Priya Tiwari
Dib-u-eegistii u dambaysayJune 2026

Dr. Priya Tiwari is a renowned medical oncologist trained at the prestigious All India Institute of Medical Sciences (AIIMS). She specializes in comprehensive cancer care and is committed to deliver... Akhri wax dheeraad ah

Qorto

All
Dr. Riya Shree

Madaxa - Adeegyada Bukaanka Caalamiga ah

Madaxa - Adeegyada Bukaanka Caalamiga ah Caafimaadka iyo Caafimaadka Qoonaq
Daaweeye kiliinikada ah

Dr. Riya Shree waa daaweeye kiliinikada ah oo ku dhameysatay tababarkeedii Cusbitaalka Mata Chanan Devi, New Delhi, iyada oo khibrad gacan ka helaysa daryeelka bukaanka iyo baxnaaninta. Waxay ka soo ... Akhri wax dheeraad ah

Websaydhkeenu wuxuu adeegsadaa cookies. Qaanuunka Arrimaha Khaaska ah.